Renata Héžová PhD
Researcher
Research activities
PREPARATION AND PURIFICATION OF RECOMBINANT PROTEINS FOR IMMUNIZATION AND DIAGNOSTIC PURPOSES
IMMUNE RESPONSE ASSESSMENT, GENE EXPRESSION
CANCER BIOLOGY
Project involvement
Pre-clinical study of non-platinum metalodrugs for lung cancer therapy
AZV NU22-08-00236
FIT (Pharmacology, Immunotherapy, nanoToxicology)
OP RDE project of the Ministry of Education, Youth and Sports of the Czech Republic – Reg.No. CZ.02.1.01/0.0/0.0/15_003/0000495
Education
2013
Ph.D. – Faculty of Medicine and Dentistry, Palacký University, Olomouc
Selected publications
Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells
Michalek J, Hezova R, Turanek-Knötigova P, Gabkova J, Strioga M, Lubitz W, Kudela P., 2017. Cancer Immunol Immunother Volume: 66(2), 149-159.
miR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus
Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Sachlova M, Svoboda M, Slaby O., 2016. Tumour Biol 37(6), 8007-18
miR-155 and miR-484 are associated with time to progression in metastatic renal cell carcinoma treated with sunitinib
Merhautova J, Hezova R, Poprach A, Kovarikova A, Radova L, Svoboda M, Vyzula R, Demlova R, Slaby O., 2015. Biomed Res Int. 941980
Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
Hezova R, Kovarikova A, Srovnal J, Zemanova M, Harustiak T, Ehrmann J, Hajduch M, Svoboda M, Sachlova M, Slaby O., 2015. Diagn Pathol. 28;10:42.
MicroRNA profiling of activated and tolerogenic human dendritic cells
Stumpfova Z, Hezova R, Meli AC, Slaby O, Michalek J., 2014. Mediators Inflamm. 259689
Microrna-342, microrna-191 and microrna-510 are differentially expressed in t regulatory cells of type 1 diabetic patients
Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J., 2009. Cell Immunol. 260:70-74